Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Oct 17 2023

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-17-2023-6

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 17, 2023, titled "Glenmark Pharmaceuticals receives ANDA approval for Apremilast Tablets, 10 mg, 20 mg and 30 mg".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases